$50.21 +0.47 (%) Abbott Laboratories - NYSE

Jul. 7, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Monday July 6, 2015

    Benzinga | Jul. 6, 2015 | 18:10PM EST
  2. Teva's Mylan bid hits snag

    IBD | Jun. 16, 2015 | 18:45PM EST
  3. Stocks End Near Highs; Perrigo Rebounds On Mylan Deal

    IBD | Jun. 16, 2015 | 17:06PM EST
  4. Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag

    IBD | Jun. 16, 2015 | 15:39PM EST
  5. Top Performing Industries For June 16, 2015

    Benzinga | Jun. 16, 2015 | 10:36AM EST
  6. Mylan Offers Response to Abbott's Support for Perrigo Deal

    Benzinga | Jun. 16, 2015 | 09:21AM EST
  7. Horizon Pharma Survives Through Transformation

    IBD | Jun. 4, 2015 | 14:17PM EST
  8. UBS Reviews ASCO, Notes Weekend Data Points From 2 Companies

    Benzinga | Jun. 1, 2015 | 09:38AM EST
  9. Breakout Watch: AbbVie Testing New Buy Point

    IBD | May. 28, 2015 | 11:26AM EST
  10. Avago Technologies Breaks Out As Stock Market Rebound Holds

    IBD | May. 27, 2015 | 15:15PM EST
  11. Making Money With Charles Payne: 05/13/15

    FoxBusiness | May. 13, 2015 | 18:00PM EST
  12. Regeneron, Nike Top Big Cap 20 Stocks Near Buy Points

    IBD | May. 11, 2015 | 19:16PM EST
  13. Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015

    Benzinga | May. 7, 2015 | 17:39PM EST
  14. 8 Dividend Stocks With The Right Qualities

    GuruFocus | Apr. 29, 2015 | 17:32PM EST
  15. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  16. Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds

    IBD | Apr. 24, 2015 | 17:51PM EST
  17. DepoMed Set To Grow On 'Transformative' Nucynta Deal

    IBD | Apr. 23, 2015 | 16:16PM EST
  18. Abbott Labs' Q1 beats views

    IBD | Apr. 22, 2015 | 18:22PM EST
  19. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 16:35PM EST
  20. Earnings Beat Propels Abbott Laboratories To New All-Time High

    Benzinga | Apr. 22, 2015 | 13:41PM EST
  21. Abbott Tops Q1 Expectations

    Benzinga | Apr. 22, 2015 | 10:58AM EST
  22. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 10:54AM EST
  23. Earnings Scheduled For April 22, 2015

    Benzinga | Apr. 22, 2015 | 04:09AM EST
  24. Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

    Benzinga | Apr. 20, 2015 | 08:38AM EST
  25. Rosetta Genomics Shares Upgraded At Cantor

    Benzinga | Apr. 17, 2015 | 09:42AM EST
  26. Mylan Q4 Earnings, Guidance In Line As Growth Ramps

    IBD | Mar. 2, 2015 | 17:14PM EST
  27. Making Money With Charles Payne: 02/23/15

    FoxBusiness | Feb. 23, 2015 | 18:00PM EST
  28. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  29. 3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis

    Benzinga | Feb. 23, 2015 | 13:57PM EST
  30. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  31. Mason Hawkins Likes Chemtura, Melco Crown; Doesn't Like Berkshire Hathaway

    Benzinga | Feb. 19, 2015 | 14:59PM EST
  32. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  33. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  34. Abbott Launches New Options for People with Cataracts in the United States

    Benzinga | Jan. 30, 2015 | 09:02AM EST
  35. Abbott Laboratories

    IBD | Jan. 29, 2015 | 18:38PM EST
  36. Thermo Fisher, Varian, Abbott Up On Earnings Reports

    IBD | Jan. 29, 2015 | 14:39PM EST
  37. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  38. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  39. Nestle & Abbott Labs To Benefit From Chinese Demand For Nutritional Products By Selling Senior-Target Products

    Benzinga | Jan. 20, 2015 | 07:42AM EST
  40. #PreMarket Primer: Friday, December 19: U.S. Debates A Response To Sony Hackers

    Benzinga | Dec. 19, 2014 | 08:17AM EST
  41. Analysts See No Sweeter Deal For Volcano

    Benzinga | Dec. 17, 2014 | 15:34PM EST
  42. Philips Buying Volcano To Boost Image-Guided Therapy

    IBD | Dec. 17, 2014 | 11:34AM EST
  43. US Stock Futures Tumble Ahead Of Producer Prices, Consumer Sentiment Data

    Benzinga | Dec. 12, 2014 | 06:52AM EST
  44. Diamond Hill Adds Two Companies to Portfolio in Third Quarter

    GuruFocus | Dec. 11, 2014 | 15:19PM EST
  45. Boston Scientific Lost the First Place in Innovation

    GuruFocus | Dec. 11, 2014 | 14:41PM EST
  46. Top 7 Dividend Aristocrats: The Best of The Best

    GuruFocus | Dec. 10, 2014 | 15:05PM EST
  47. Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin

    Benzinga | Dec. 9, 2014 | 05:09AM EST
  48. 6 Stocks Giving Investors Potential Dividend Hikes In December

    GuruFocus | Dec. 4, 2014 | 13:05PM EST
  49. Fast Money Picks For December 3: Canadian Pacific, Abbott Labs, BlackBerry And Ford

    Benzinga | Dec. 3, 2014 | 07:47AM EST
  50. Jon Najarian Sees Unusual Options Activity In Abbott Laboratories

    Benzinga | Dec. 3, 2014 | 07:31AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!